692 filings
Page 5 of 35
8-K
u3a74h6jugoxl4u8
10 Nov 20
Five Prime Announces Bemarituzumab Plus Chemotherapy Demonstrates
5:19pm
4
8w60adhnv28z52n4v
6 Nov 20
FIVE PRIME THERAPEUTICS / PARTNERS L P/IL BVF ownership change
6:30pm
8-K
bdpl5d
3 Nov 20
Five Prime Therapeutics Reports Third Quarter 2020 Results
4:10pm
8-K
rzshn7 e5c
2 Nov 20
Five Prime to Present First Pre-clinical Data of Anti-CCR8 Antibody FPA157
5:11pm
4
hm2og9de9llnsg
8 Oct 20
FIVE PRIME THERAPEUTICS / PARTNERS L P/IL BVF ownership change
5:27pm
SC 13D/A
xdihqc1h l7
8 Oct 20
FIVE PRIME THERAPEUTICS / BIOTECHNOLOGY VALUE FUND L P ownership change
5:26pm
4
x5p99 bcc1
2 Oct 20
FIVE PRIME THERAPEUTICS / David White ownership change
1:51pm
4
z3kfyra hke13c
24 Sep 20
FIVE PRIME THERAPEUTICS / PARTNERS L P/IL BVF ownership change
7:49pm
8-K
exnzcg99
4 Sep 20
Entry into a Material Definitive Agreement
12:00am
8-K
6hwso93
1 Sep 20
Departure of Directors or Certain Officers
6:07am
4
g29xwkrcv5hhwp6luf
24 Aug 20
FIVE PRIME THERAPEUTICS / Helen Louise Collins ownership change
1:46pm
8-K
6r493es5s3smy2jung
6 Aug 20
Five Prime Therapeutics Reports Second Quarter 2020 Results
4:31pm
424B5
dgxj4b6go7zkrambym
6 Aug 20
Prospectus supplement for primary offering
4:28pm
CT ORDER
lc29v8hr0
5 Aug 20
Confidential treatment order
12:00am
CT ORDER
dp4ab8f 5ci35w
3 Aug 20
Confidential treatment order
12:17pm
4
chlf4
20 May 20
FIVE PRIME THERAPEUTICS / WILLIAM R RINGO ownership change
4:14pm
8-K
tl48qz coc708n2nct
20 May 20
Submission of Matters to a Vote of Security Holders
4:06pm
4
4zxdtxhj8kgtj
18 May 20
FIVE PRIME THERAPEUTICS / PARTNERS L P/IL BVF ownership change
8:02pm